University of Illinois at Chicago
Announcement of an Exempt Purchase
Vendor: Celltrans, Incorporated, Chicago, IL
Amount: An estimated $270,000
An estimated start date of 1/17/2019 through 1/16/2020
The University award process may be delayed up to thirty days as this award goes through a state approval process.
First published Friday, January 18, 2019
The University awarded a contract for prepared and isolated islet cells.
Celltrans will prepare and isolate islet cells from donated pancreases to support islet cell transplantation into patients.
This purchase is exempt from the usual selection processes of the Procurement Code because the procurement expenditure is for medical supplies or medical services necessary for the delivery of care and treatment at medical, dental, or veterinary teaching facilities utilized by SIU or U of I (30 ILCS 500 / 1-13(b-5)) Celltrans holds a licensing agreement for a proven methodology for the isolation and preparation of islet cells for human transplantation. This therapy is important for the treatment of patients with otherwise uncontrolled diabetes and serves as an important adjunct to pancreatic transplant. These services are required for the University of Illinois Hospital to provide the full spectrum of advanced care for diabetes.
For additional information, contact:
The State of Illinois has a policy to encourage prospective vendors to hire
qualified veterans, minorities, females, persons with disabilities and ex-offenders.